6615 Stock Overview
Provides genetic testing services in Taiwan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Sofiva Genomics Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$56.60 |
| 52 Week High | NT$56.60 |
| 52 Week Low | NT$37.30 |
| Beta | 0.16 |
| 1 Month Change | 25.78% |
| 3 Month Change | 34.60% |
| 1 Year Change | 33.96% |
| 3 Year Change | 20.43% |
| 5 Year Change | -35.75% |
| Change since IPO | -37.80% |
Recent News & Updates
Recent updates
Some Investors May Be Worried About Sofiva GenomicsLtd's (GTSM:6615) Returns On Capital
Apr 14
Estimating The Fair Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)
Mar 18Sofiva Genomics Co.,Ltd. (GTSM:6615) Investors Should Think About This Before Buying It For Its Dividend
Feb 24Should Weakness in Sofiva Genomics Co.,Ltd.'s (GTSM:6615) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jan 27Our Take On The Returns On Capital At Sofiva GenomicsLtd (GTSM:6615)
Jan 07
A Look At The Intrinsic Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)
Dec 15Read This Before Buying Sofiva Genomics Co.,Ltd. (GTSM:6615) For Its Dividend
Nov 24Shareholder Returns
| 6615 | TW Healthcare | TW Market | |
|---|---|---|---|
| 7D | 15.5% | 0.5% | -1.5% |
| 1Y | 34.0% | -12.3% | 25.5% |
Return vs Industry: 6615 exceeded the TW Healthcare industry which returned -12.7% over the past year.
Return vs Market: 6615 exceeded the TW Market which returned 27.9% over the past year.
Price Volatility
| 6615 volatility | |
|---|---|
| 6615 Average Weekly Movement | 7.9% |
| Healthcare Industry Average Movement | 3.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in TW Market | 8.5% |
| 10% least volatile stocks in TW Market | 2.3% |
Stable Share Price: 6615's share price has been volatile over the past 3 months.
Volatility Over Time: 6615's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | n/a | n/a | www.sofivagenomics.com.tw |
Sofiva Genomics Co.,Ltd. provides genetic testing services in Taiwan and internationally. The company offers prenatal services, including thalassemia carrier screening; tests for microdeletion syndromes and single-gene abnormalities; detection of common chromosome abnormalities, selected microdeletions syndromes, and selected skeletal dysplasia genetic mutations; multiple genetic diseases detection; folate metabolism genetic screening; spinal muscular atrophy carrier screening; fragile X syndrome carrier screening; congenital infection screening; risk assessment for early/late-onset preeclampsia; maternal serum screening for down syndrome; and karyotyping.
Sofiva Genomics Co.,Ltd. Fundamentals Summary
| 6615 fundamental statistics | |
|---|---|
| Market cap | NT$1.21b |
| Earnings (TTM) | NT$19.83m |
| Revenue (TTM) | NT$474.81m |
61.0x
P/E Ratio2.5x
P/S RatioIs 6615 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6615 income statement (TTM) | |
|---|---|
| Revenue | NT$474.81m |
| Cost of Revenue | NT$336.90m |
| Gross Profit | NT$137.91m |
| Other Expenses | NT$118.08m |
| Earnings | NT$19.83m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.93 |
| Gross Margin | 29.05% |
| Net Profit Margin | 4.18% |
| Debt/Equity Ratio | 0% |
How did 6615 perform over the long term?
See historical performance and comparison